Burkina Faso vs Mexico: Prevalence rate of hypertension in women aged 30-79
Burkina Faso
31.7
in 2019
Mexico
31.4
in 2019
Burkina Faso rank
146th
Mexico rank
148th
Prevalence rate of hypertension in women aged 30-79 over time
- Burkina Faso
- Mexico
How they compare
Burkina Faso currently reports 31.7 against 31.4 in Mexico, a difference of 0.3.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Burkina Faso ahead.
Burkina Faso ranks 146th and Mexico ranks 148th of 195 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | Burkina Faso | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 32.06 | 31.5 | 0.56 | Burkina Faso |
| 2000s | 32.92 | 33.9 | 0.98 | Mexico |
| 2010s | 32.26 | 32.96 | 0.7 | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Burkina Faso or Mexico?
- Burkina Faso, at 31.7 against 31.4 in Mexico as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Burkina Faso and Mexico?
- 0.3, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Mexico?
- 30 years are reported by both, from 1990 to 2019.
- How do Burkina Faso and Mexico rank globally for prevalence rate of hypertension in women aged 30-79?
- Burkina Faso ranks 146th and Mexico ranks 148th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.